1. Professor MH. Olsen inaugural seminar 3/10 14. 00-18
Professor MH. Olsen inaugural seminar 3/ From better characterization to better treatment
Introduction (Ole Skøtt/MHO) minutes
Early vascular ageing (EVA) (Stephane Laurent) minutes
Prognostic importance of subclinical cardiovascular damage( )
Subclinical cardial damage (MPP) (Manan Pareek) minutes
Subclinical vascular damage (MONI10) (Sara V. Greve) minutes
PWV estimated by BP and age (MORGAM) (MHO for Julie Vishram) 10+2 minutes
Subclinical vascular damage and ABPM (MONI10) (Thomas Olesen) 10+2 minutes
Prognostic importance of age/sex for TOD (MONI10) (Jacob Stidsen)10+2 minutes
Coronary artery Calcium Score (DanRISK) (Axel Diederichsen) 10+2 minutes
Coronar atherosclerosis in type 2 diabetes (T2D) (Monija Mrgan) 10+2 minutes
Coffee break ( ) minutes
Individualized treatment of T2D (IDA) (Henning Beck-Nielsen) 25+5 minutes
Ongoing projects ( )
Prediction of T2D/CVD (MONI10, MPP) (Mette Nielsen/Marie Blicher) 10+2 minutes
Prediction of T2D/CVD using biomarkers (MPP) (Martin Magnusson) 10+2 minutes
New biomarkers and aortic valve stenosis (SEAS) (Olav W. Nielsen) 10+2 minutes
DanCAVAS/FiSICH/DiaCAVAS (Axel Diederichsen) minutes
Pt. with ischemic heart disease and type 2 diabetes (Ilan Raymond) 10+2 minutes
Electronic decision support and future PhD projects ( )
(MONICA, MPP, SEAS, Paris, MORGAM) (Michael H. Olsen) 25+5 minutes
Closing remarks (Michael H. Olsen) 5 minutes